StephenBarriHeitnerMDFACC, FASE

Adult Congenital Heart Disease, Echocardiography, Heart Failure & Transplantation

Senior Medical Director, cardiovascular Cytokinetics inc.

Dr. Heitner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9427 SW Barnes Rd
Ste 495
Portland, OR 97225
Phone+1 503-216-1661

Fax+1 503-418-9195

Dr. Stephen Heitner is a cardiologist in Portland, OR and is affiliated with OHSU Hospital. He received his medical degree from University of the Witwatersrand and has been in practice 18 years. He specializes in adult congenital heart disease, echocardiography, and heart failure & transplantation and is experienced in general cardiology, echocardiography, nuclear cardiology, and advanced cardiac imaging.

Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Cardiovascular Disease, 2008 - 2011
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2004 - 2008
University of the WitwatersrandClass of 1999

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Fellow (FACC) American College of Cardiology

PubMed

Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten.
Donghong Xu, Justin D Lutz, Punag Divanji, Jianlin Li, Youcef Benattia
Clinical Pharmacokinetics. 2025-03-01
Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics.
Pablo Garcia-Pavia, Ozlem Bilen, Melissa Burroughs, Juan Pablo Costabel, Edileide de Barros Correia
JACC. Heart Failure. 2025-02-01
1 citations
External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as refer...
Valentina Roquemen-Echeverri, Peter G Jacobs, Evan F Shalen, Peter M Schulman, Stephen B Heitner
International Journal of Cardiology. 2025-01-15

Journal Articles

Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History
Stephen Heitner, MD, JAMA Cardiology

Abstracts/Posters

[Board 518] Long-Term Safety and Effectiveness of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy Patients PIONEER-Open Label Extension Study (PIONE...
Stephen Heitner, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
[Board 279] Implantable Cardioverter-Defibrillators For Children With Cardiac Conditions Associated With High Risk For Sudden Cardiac Death: A Cost-Effectiveness Analy...
Stephen Heitner, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019
[Board 561] Home AEDs For Children With Cardiac Conditions Associated With Intermediate Risk For Sudden Cardiac Death: A Cost-Effectiveness Analysis
Stephen Heitner, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019

Lectures

AG10 Consistently Stabilizes Transthyretin to a High Level in Both Wild Type and Mutant Amyloid Cardiomyopathy: Responder Analyses From a Phase 2 Clinical Trial
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in HistoryJune 2020

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & ExpoMarch 17th, 2025
Additional Data from SEQUOIA-HCM Presented at HFSA Annual Scientific MeetingOctober 2nd, 2024
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific SessionsSeptember 27th, 2024
Join now to see all